The effect of inspiration time on the emitted dose from the mometasone furoate dry powder inhaler

被引：0
|
作者：
Yang, TT [1 ]
Li, S [1 ]
Wyka, B [1 ]
Kenyon, D [1 ]
机构：
[1] Schering Plough Res Inst, Kenilworth, NJ USA
来源：
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY | 2001年 / 107卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
345
引用
收藏
页码：S103 / S103
页数：1
相关论文
共 50 条
  • [1] Mometasone furoate dry powder inhaler for the treatment of asthma
    Fausnight, Tracy B.
    Craig, Timothy J.
    EXPERT OPINION ON PHARMACOTHERAPY, 2011, 12 (17) : 2707 - 2712
  • [2] Drug delivery performance of the mometasone furoate dry powder inhaler
    Yang, TT
    Li, S
    Wyka, B
    Kenyon, D
    JOURNAL OF AEROSOL MEDICINE-DEPOSITION CLEARANCE AND EFFECTS IN THE LUNG, 2001, 14 (04): : 487 - 494
  • [3] Dose-ranging study of a new steroid for asthma: mometasone furoate dry powder inhaler
    Bernstein, DI
    Berkowitz, RB
    Chervinsky, P
    Dvorin, DJ
    Finn, A
    Gross, GN
    Karetzky, M
    Kemp, JP
    Laforce, C
    Lumry, W
    Mendelson, LM
    Nelson, H
    Pearlman, D
    Rachelefsky, G
    Ratner, P
    Repsher, L
    Segal, AT
    Selner, JC
    Settipane, GA
    Wanderer, A
    Cuss, FM
    Nolop, KB
    Harrison, JE
    RESPIRATORY MEDICINE, 1999, 93 (09) : 603 - 612
  • [4] Retention of dose uniformity with the new mometasone furoate dry powder inhaler (MF-DPI)
    Kenyon, D
    Yang, TT
    Ambrosio, T
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2000, 105 (01) : S14 - S15
  • [5] Investigation of Appropriate Inhalation Technique for Mometasone Furoate Dry Powder Inhaler
    Yokoyama, Haruko
    Ito, Kanako
    Mihashi, Hirokazu
    Shiraishi, Yasuyuki
    Takayanagi, Risa
    Yamada, Yasuhiko
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2016, 39 (10) : 1576 - 1580
  • [6] Mometasone furoate dry-powder inhaler for the control of persistent asthma
    D'Urzo, Anthony
    EXPERT OPINION ON PHARMACOTHERAPY, 2007, 8 (16) : 2871 - 2884
  • [7] Comparison of the systemic bioavailability of mometasone furoate after oral inhalation from a mometasone furoate/formoterol fumarate metered-dose inhaler versus a mometasone furoate dry-powder inhaler in patients with chronic obstructive pulmonary disease
    Kosoglou, Teddy
    Hubbell, James
    Xuan, Fengjuan
    Cutler, David L.
    Meehan, Alan G.
    Kantesaria, Bhavna
    Wittmer, Bret A.
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2013, 8 : 107 - 116
  • [8] Comparative efficacy and safety of mometasone furoate dry powder inhaler and budesonide Turbuhaler®
    Carlsson, LG
    Edsbäcker, S
    EUROPEAN RESPIRATORY JOURNAL, 2001, 17 (06) : 1332 - 1333
  • [9] Effects of treatment with mometasone furoate dry powder inhaler in children with persistent asthma
    Berger, William E.
    Milgrom, Henry
    Chervinsky, Paul
    Noonan, Michael
    Weinstein, Steven F.
    Lutsky, Barry N.
    Staudinger, Heribert
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2006, 97 (05) : 672 - 680
  • [10] Comparison of the efficacy and safety of mometasone furoate dry powder inhaler to budesonide Turbuhaler®
    Bousquet, J
    D'Urzo, A
    Hebert, J
    Barraza, CH
    Boulet, LP
    Suárez-Chacón, R
    Harnest, U
    Lundbäck, B
    Morales, GM
    Nieminen, MM
    Nolop, KB
    Visser, S
    Lutsky, BN
    EUROPEAN RESPIRATORY JOURNAL, 2000, 16 (05) : 808 - 816
12345